The Recall Desk
Agency classClass IIOur severity:HighFDA (Drugs)·D-0414-2026·Announced 2026-04-08

GNP redness and dry eye relief drops recalled over sterility assurance

GNP Eye Drops Redness and Dry Eye Relief, containing glycerin and naphazoline hydrochloride, are being recalled for lack of assurance of sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported: this is an FDA Class II recall of a sterile ophthalmic product whose sterility cannot be assured, with no injuries stated.

Plain-English summary

GNP Eye Drops Redness and Dry Eye Relief (glycerin, naphazoline hydrochloride) are being recalled. About 315,144 bottles were distributed nationwide in the United States. The FDA has classified this recall as Class II.

The recall was initiated for lack of assurance of sterility.

Affected product covers lot RL24D01 (expiry 04/30/26) and lots RL24F01 and RL24F02 (expiry 06/30/26), across multiple package configurations listed in the FDA enforcement record.

Consumers and pharmacies can identify affected product by the lot numbers and expiry dates above, and may contact the recalling firm for further information.

The recalled product

Product
LEADER EYE DROPS REDNESS RELIEF (GLYCERIN, NAPHAZOLINE HYDROCHLORIDE)
Brand
LEADER EYE DROPS REDNESS RELIEF
Manufacturer
K.C. Pharmaceuticals, Inc
Category
Drug — Ophthalmic
Hazard
Affected units
315,144

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (15)

  • Lot: a) RL24D01
  • Exp.: 04/30/26
  • RL24F01
  • RL24F02
  • Exp.:06/30/26
  • b) RL24F01
  • c) RL24F01
  • d) RL24F02
  • e) RL24F01
  • f) RL24F01
  • g) RL24F01
  • h) RL24F01
  • i) RL24F01
  • j) RL24F02
  • k)

UPCs (8)

  • 0096295137620
  • 0096295137637
  • 0010939958310
  • 348201016155
  • 348201016131
  • 041163461512
  • 311917177410
  • 093351034114

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 8 recalled by K.C. Pharmaceuticals, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 8 products in this recall →

Related recalls

Same brand · LEADER EYE DROPS REDNESS RELIEF

Same manufacturer · K.C. Pharmaceuticals, Inc

See all →

Same hazard · sterility failure

See all →

Similar recalls